{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:24:57Z","timestamp":1786965897472,"version":"build-2736575974"},"reference-count":99,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Chronic liver disease significantly distresses patients\u2019 health-related quality of life (HRQoL). Factors such as ascites, hepatic encephalopathy, medication side effects, malnutrition, sarcopenia, frailty, the prospect of liver transplantation, caregiver reliance, financial burdens, and future uncertainty can all negatively influence HRQoL. Evaluating HRQoL in liver disease is critical. Recognizing factors that impair HRQoL in these patients enables the multidisciplinary team to promote health in a comprehensive biopsychosocial approach to well-being.  Methods: We searched the PubMed database using these descriptors: health-related quality of life, cirrhosis, liver disease, alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, liver transplantation, sarcopenia, frailty, and malnutrition.  Results: HRQoL is negatively affected by the severity of liver disease and its complications. Moreover, nutritional and psychological aspects such as sarcopenia, frailty, malnutrition, fear of disease progression and need for transplantation, feeling of dependence on caregivers, and financial impacts of the disease also culminate in reduced quality of life.  Conclusion: People with chronic liver disease experience a significant impairment in their quality of life due to various clinical, nutritional, and social factors. For this reason, a multidisciplinary, global assessment with systematic appreciation of HRQoL at each consultation is essential when following these patients.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612026-064","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:38:02Z","timestamp":1786963082000},"source":"Crossref","is-referenced-by-count":0,"title":["HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LIVER DISEASE: CLINICAL BURDEN, DETERMINANTS, AND IMPLICATIONS FOR PATIENT-CENTERED CARE"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-220X","authenticated-orcid":false,"given":"Maria Gabriela Fernandes","family":"DEZAN","sequence":"first","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil; Universidade Federal da Bahia,  Brasil; Instituto Do\u2019r de Ensino e Pesquisa,  Brasil; Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8427-610X","authenticated-orcid":false,"given":"Caio Pedro Gomes da","family":"HORA","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3244-5503","authenticated-orcid":false,"given":"Catharina Ribeiro","family":"LYRA","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-0931","authenticated-orcid":false,"given":"Lourianne Nascimento","family":"CAVALCANTE","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil; Universidade Federal da Bahia,  Brasil; Instituto Do\u2019r de Ensino e Pesquisa,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7698-6919","authenticated-orcid":false,"given":"Helma Pinchemel","family":"COTRIM","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil; Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-8645","authenticated-orcid":false,"given":"Andr\u00e9 Castro","family":"LYRA","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil; Universidade Federal da Bahia,  Brasil; Instituto Do\u2019r de Ensino e Pesquisa,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11894-002-0041-z","article-title":"The Impact of Liver Disease on Health-related Quality of Life: A Review of the Literature","volume":"4","author":"Martin LM","year":"2002","journal-title":"Curr Gastroenterol Rep"},{"key":"ref2","first-page":"1","article-title":"Factors Affecting and Promoting Health-related Quality of Life in Patients With Liver Cirrhosis: An Underestimated Domain in Patient Care","volume":"14","author":"Rajupurohit S","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2014.06.034","article-title":"Health related quality of life in people with advanced chronic liver disease","volume":"61","author":"Orr JG","year":"2014","journal-title":"J Hepatol"},{"key":"ref4","first-page":"227","article-title":"Overview of research on health-related quality of life in patients with chronic liver disease","volume":"65","author":"Gutteling JJ","year":"2007","journal-title":"Neth J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1590\/S1415-790X2013000400009","article-title":"Brazilian normative data for the Short Form 36 questionnaire, version 2","volume":"16","author":"Laguardia J","year":"2013","journal-title":"Rev Bras Epidemiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and Item Selection","volume":"30","author":"Ware Jr JE","year":"1992","journal-title":"Med Care"},{"key":"ref7","first-page":"185","article-title":"Measuring health status: a new tool for clinicians and epidemiologists","author":"Hunt SM","year":"1985","journal-title":"J R Coll Gen Pract"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The Sickness Impact Profile: Development and Final Revision of a Health Status Measure","volume":"19","author":"Bergner M","year":"1981","journal-title":"Med Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/S0102-311X2010000100021","article-title":"Cross-cultural adaptation of the Chronic Liver Disease Questionnaire (CLDQ) to the Brazilian population","volume":"26","author":"Mucci S","year":"2010","journal-title":"Cad Saude Publica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi ZM","year":"1999","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1111\/j.1572-0241.2000.03375.x","article-title":"Development and Evaluation of the Liver Disease Quality of Life Instrument in Persons With Advanced, Chronic Liver Disease - The LDQOL 1.0","volume":"95","author":"Gralnek IM","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/liv.14680","article-title":"Factors Associated with Health-related Quality of Life in Patients with Cirrhosis: A Systematic Review","volume":"41","author":"Rabiee A","year":"2021","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis","volume":"33","author":"Peng JK","year":"2019","journal-title":"Palliat Med"},{"key":"ref15","first-page":"1","article-title":"Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study","volume":"19","author":"Lee MK","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5114\/ceh.2018.80124","article-title":"Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires","volume":"4","author":"Janani K","year":"2018","journal-title":"Clin Exp Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MEG.0b013e3283319975","article-title":"Quality of life in cirrhosis is related to potentially treatable factors","volume":"22","author":"Les I","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref18","first-page":"1","article-title":"Predictors of Health-Related Quality of Life in Outpatients with Cirrhosis: Results from a Prospective Cohort","volume":"2013","author":"Thiele M","year":"2013","journal-title":"Hepatol Res Treat"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.14309\/ajg.0000000000000545","article-title":"Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis","volume":"115","author":"Kok B","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apt.14824","article-title":"Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients","volume":"48","author":"Labenz C","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of Hepatic Encephalopathy on Health-Related Quality of Life in Patients with Cirrhosis","volume":"48","author":"Arguedas MR","year":"2003","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2036.2011.04808.x","article-title":"Rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double blind placebo-controlled study","volume":"34","author":"Sanyal A","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin Improves Psychometric Performance and Health-Related Quality of life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)","volume":"106","author":"Sidhu SS","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose Improves Cognitive Functions and Health-Related Quality of Life in Patients with Cirrhosis Who Have Minimal Hepatic Encephalopathy","volume":"45","author":"Prasad S","year":"2007","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jfma.2016.05.006","article-title":"Quality of life among patients suffering from cholestatic liver disease-induced pruritus: A systematic review","volume":"115","author":"Jin XY","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2024.04.008","article-title":"Assessment of fatigue and its impact in chronic liver disease","volume":"81","author":"Younossi ZM","year":"2024","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0 E","year":"2012","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11136-018-1813-8","article-title":"Patients with refractory ascites treated with alfapump\u00ae system have better health-related quality of life as compared to those treated with large volume paracentesis: results of multicenter randomized controlled study","volume":"27","author":"Stepanova M","year":"2018","journal-title":"Qual Life Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.25724","article-title":"Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump","volume":"26","author":"Wong F","year":"2020","journal-title":"Liver Transpl"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cgh.2024.09.035","article-title":"Influence of Comorbidities on Health-Related Quality of life in Alcohol-Related Liver Disease: A Population-Based Survey","volume":"23","author":"Elde KD","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref31","first-page":"1","article-title":"Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis","volume":"8","author":"Luk JW","year":"2024","journal-title":"Hepatol Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-025-02399-3","article-title":"Impact of liver cirrhosis on health-related quality of life in Indian patients: interplay of disease severity, alcohol dependence and malnutrition","volume":"23","author":"Singh AK","year":"2025","journal-title":"Health Qual Life Outcomes"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2024.02.010","article-title":"Changing from NAFLD to MASLD: The implications for health-related data","volume":"80","author":"Hashida R","year":"2024","journal-title":"J Hepatol"},{"key":"ref34","first-page":"1","article-title":"The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease","volume":"6","author":"Younossi ZM","year":"2024","journal-title":"JHEP Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.cgh.2023.04.018","article-title":"Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study","volume":"21","author":"Papatheodoridi M","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpsychores.2018.07.004","article-title":"Quality of life in patients with nonalcoholic fatty liver disease: A systematic review","volume":"112","author":"Assimakopoulos K","year":"2018","journal-title":"J Psychosom Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomized, placebo-controlled phase 2 study","volume":"387","author":"Armstrong MJ","year":"2016","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis","volume":"362","author":"Sanyal AJ","year":"2010","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/apt.17598","article-title":"Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomized trial","volume":"58","author":"Romero-G\u00f3mez M","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2021.07.039","article-title":"Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life","volume":"20","author":"Younossi ZM","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.28416","article-title":"Weight Loss Results in Significant Improvements in Quality of Life for Patients with Nonalcoholic Fatty Liver Disease: A prospective Cohort Study","volume":"63","author":"Tapper EB","year":"2016","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ppc.12269","article-title":"Effect of hepatitis C infection on the quality of life","volume":"54","author":"Horv\u00e1th G","year":"2018","journal-title":"Perspect Psychiatr Care"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/00365520902898135","article-title":"Health-related quality of life in patients with different stages of liver disease induced by hepatitis C","volume":"44","author":"Bj\u00f6rnsson E","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0748-8","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life","volume":"15","author":"Smith-Palmer J","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11136-019-02111-1","article-title":"Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population","volume":"28","author":"Juanbelz R","year":"2019","journal-title":"Qual Life Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s11136-021-02874-6","article-title":"Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response","volume":"30","author":"Miyasaka A","year":"2021","journal-title":"Qual Life Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0168-8278(00)00026-X","article-title":"The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity","volume":"34","author":"McHutchison JG","year":"2001","journal-title":"J Hepatol"},{"key":"ref48","first-page":"31","article-title":"The Effect of Interferon Alpha plus Ribavirin on Health-Related Quality of Life in Chronic C Hepatitis. The Romanian Experience.","volume":"15","author":"Pojoga C","year":"2006","journal-title":"J Gastrointest Liver Dis"},{"key":"ref49","first-page":"1","article-title":"Health-related quality of life in Thai patients with chronic hepatitis B","volume":"12","author":"Chantrakul R","year":"2024","journal-title":"Gastroenterol Rep"},{"key":"ref50","first-page":"1","article-title":"Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B: A Cross-Sectional Assessment in Southeastern China","volume":"2021","author":"Chen P","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/PPA.S127139","article-title":"Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment","volume":"11","author":"Xue X","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4269\/ajtmh.19-0007","article-title":"Effects of Depression, Anxiety, Stigma, and Disclosure on Health-Related Quality of Life among Chronic Hepatitis B Patients in Dalian, China","volume":"102","author":"Li G","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"ref53","first-page":"229","article-title":"Is there an association between Health Related Quality of Life, socio-demographic status and Fatigue in Patients with Chronic Hepatitis B?","volume":"80","author":"Saffari M","year":"2017","journal-title":"Acta Gastro-Enterol Belg"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4254\/wjh.v13.i11.1642","article-title":"Health-related quality of life in autoimmune hepatitis","volume":"13","author":"Snijders RJ","year":"2021","journal-title":"World J Hepatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s11136-021-02850-0","article-title":"Health-related quality of life in patients with autoimmune hepatitis","volume":"30","author":"Michel M","year":"2021","journal-title":"Qual Life Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HMER.S256692","article-title":"Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and impact on Quality of Life","volume":"13","author":"Sivakumar T","year":"2021","journal-title":"Hepat Med Evid Res"},{"key":"ref57","first-page":"1","article-title":"Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study","volume":"9","author":"Smith HT","year":"2025","journal-title":"Hepatol Commun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cgh.2020.06.025","article-title":"Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom","volume":"19","author":"Rice S","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s10620-015-4013-1","article-title":"Factors that influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis","volume":"61","author":"Cheung AC","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cgh.2012.01.025","article-title":"Factors that Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis","volume":"10","author":"de Valle MB","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/liv.15542","article-title":"Health-related quality of life in patients with primary sclerosing cholangitis: A longitudinal population-based cohort study","volume":"43","author":"Mol B","year":"2023","journal-title":"Liver Int"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clinre.2015.09.007","article-title":"Wilson disease: Health-related quality of life and risk for depression","volume":"40","author":"Schaefer M","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm12144823","article-title":"Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study","volume":"12","author":"Mari\u00f1o Z","year":"2023","journal-title":"J Clin Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-016-0431-9","article-title":"Quality of life utility values for hereditary haemochromatosis in Australia","volume":"14","author":"de Graaff B","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"ref65","first-page":"1","article-title":"Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period","volume":"13","author":"Acevedo LAU","year":"2022","journal-title":"Genes"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11136-006-9131-y","article-title":"Generic and disease-specific health related quality of life of liver patients with various aetiologies: A survey","volume":"16","author":"van der Plas SM","year":"2007","journal-title":"Qual Life Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.3748\/wjg.v12.i48.7792","article-title":"Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania","volume":"12","author":"Sumskiene J","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aohep.2020.10.005","article-title":"Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience","volume":"22","author":"Castellanos-Fern\u00e1ndez MI","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1478-3231.2007.01606.x","article-title":"Liver transplantation and quality of life: relevance of a specific liver disease questionnaire","volume":"28","author":"Gotardo DRM","year":"2008","journal-title":"Liver Int"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-8-46","article-title":"Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study","volume":"8","author":"Kalaitzakis E","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"ref71","first-page":"1","article-title":"Hepatocellular carcinoma and its impact on quality of life: A review of the qualitative literature","volume":"31","author":"Norman EML","year":"2022","journal-title":"Eur J Cancer Care"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3348\/kjr.2019.0808","article-title":"Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018","volume":"21","author":"Kang D","year":"2020","journal-title":"Korean J Radiol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cgh.2010.03.008","article-title":"Health-Related Quality of Life in Patients With Hepatocellular Carcinoma: A systematic Review","volume":"8","author":"Fan SY","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/liv.13593","article-title":"Quality of life as a prognostic factor for survival in hepatocellular carcinoma","volume":"38","author":"Eilard MS","year":"2018","journal-title":"Liver Int"},{"key":"ref75","first-page":"1","article-title":"Factors related to the quality of life in liver cancer patients during treatment phase: A follow-up study","volume":"26","author":"Li IF","year":"2019","journal-title":"Eur J Cancer Care"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jvir.2019.07.020","article-title":"Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies of Hepatocellular Carcinoma","volume":"30","author":"Das A","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00432-019-03005-y","article-title":"Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma","volume":"145","author":"Wehling C","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.transproceed.2016.04.012","article-title":"Health-Related Quality of Life and Psychological Distress in Patients With Early-Stage Hepatocellular Carcinoma After Hepatic Resection or Transplantation","volume":"48","author":"Lei JY","year":"2016","journal-title":"Transplant Proc"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s11136-015-0985-8","article-title":"Quality of life changes in patients undergoing treatment for hepatocellular carcinoma","volume":"24","author":"Chie WC","year":"2015","journal-title":"Qual Life Res"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43046-025-00267-1","article-title":"Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90","volume":"37","author":"Bress K","year":"2025","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.33317","article-title":"Health-Related Quality-of-Life Impact of Pembrolizumab Versus Best Supportive Care in Previously Systemically Treated Patients With Advanced Hepatocellular Carcinoma: KEYNOTE-240","volume":"127","author":"Ryoo BY","year":"2021","journal-title":"Cancer"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"101684","DOI":"10.1016\/j.bpg.2020.101684","article-title":"Quality of life after liver transplantation","volume":"46-47","author":"Aberg F","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life","volume":"34","author":"Yang LS","year":"2014","journal-title":"Liver Int"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1053\/j.gastro.2010.06.043","article-title":"In a 12-Year Study, Sustainability of Quality of Life Benefits After Liver Transplantation Varies With Pretransplantation Diagnosis","volume":"139","author":"Ruppert K","year":"2010","journal-title":"Gastroenterology"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/lt.21561","article-title":"Quality of Life up to 30 years Following Liver Transplantation","volume":"14","author":"Desal R","year":"2008","journal-title":"Liver Transpl"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/SLA.0b013e3181f5f23a","article-title":"Long-Term Patient Outcome and Quality of Life After Liver Transpl antation. Analysis of 20-Year Survivors","volume":"252","author":"Duffy JP","year":"2010","journal-title":"Ann Surg"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.transproceed.2015.11.009","article-title":"Identifying Improved and Non-improved Aspects of Health-Related Quality of Life After Liver Transpl antation Based on Assessment of The Specific Questionnaire Liver Disease Quality of Life","volume":"48","author":"Casanovas T","year":"2016","journal-title":"Transplant Proc"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/lt.20812","article-title":"Sexual Functioning in Patients With End-Stage Liver Disease Before and After Transplantation","volume":"12","author":"Sorrell JH","year":"2006","journal-title":"Liver Transpl"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-015-0232-3","article-title":"Assessment of nutritional status and health-related quality of life before and after liver transplantation","volume":"15","author":"Garc\u00eda-Rodr\u00edguez MT","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"ref90","first-page":"1","article-title":"Health-Related Quality of Life and Frailty in Chronic Liver Diseases","volume":"10","author":"Nishikawa H","year":"2020","journal-title":"Life"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm12165348","article-title":"Frailty Predicting Health-Related Quality of Life Trajectories in Individuals with Sarcopenia in Liver Cirrhosis: Finding from BCAAS Study","volume":"12","author":"Nathiya D","year":"2023","journal-title":"J Clin Med"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/MEG.0000000000001472","article-title":"Sarcopenia impairs health-related quality of life in cirrhotic patients","volume":"31","author":"Ando Y","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/17474124.2021.1848542","article-title":"Clinical impact of sarcopenia assessment in patients with liver cirrhosis","volume":"15","author":"Marasco G","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4103\/jfmpc.jfmpc_149_25","article-title":"Factors influencing and enhancing health-related quality of life in sarcopenia patients with liver cirrhosis: A comprehensive review","volume":"14","author":"Bhagchandani D","year":"2025","journal-title":"J Family Med Prim Care"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/apt.15084","article-title":"Quality of life measures predict mortality in patients with cirrhosis and severe ascites","volume":"49","author":"Macdonald S","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref96","first-page":"1","article-title":"Health-related quality of life and survival in Chinese patients with chronic liver disease","volume":"11","author":"Gao F","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"ref97","first-page":"661","article-title":"The Current Economic Burden of Cirrhosis","volume":"7","author":"Neff GW","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep4.1526","article-title":"Burden of Cirrhosis on Patients and Caregivers","volume":"4","author":"Volk ML","year":"2020","journal-title":"Hepatol Commun"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph20085497","article-title":"Mental Health, Quality of Life, and Stigmatization in Danish Patients with Liver Disease","volume":"20","author":"Ostberg N","year":"2023","journal-title":"Int J Environ Res Public Health"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Qualidade de vida relacionada \u00e0 sa\u00fade na doen\u00e7a hep\u00e1tica cr\u00f4nica: impacto cl\u00ednico, determinantes e implica\u00e7\u00f5es para o cuidado centrado no paciente"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032026000105013&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:38:16Z","timestamp":1786963096000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032026000105013&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":99,"alternative-id":["S0004-28032026000105013"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612026-064","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e26064"}}